Please wait while the formulary information is being retrieved.
MYCAMINE (MICAFUNGIN SODIUM)
- Candida peritonitis
- Candidal septicemia
- Candidemia
- Disseminated candidiasis
- Esophageal candidiasis
- Prevention of disseminated candidiasis
100 mg intravenous solution
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
50 mg intravenous solution
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
Candida peritonitis
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
Candidal septicemia
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
Candidemia
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
Disseminated candidiasis
- Infuse 100 mg over 60 minute(s) by intravenous route once daily
Esophageal candidiasis
- Infuse 150 mg over 1 hour(s) by intravenous route once daily
- Infuse 150 mg over 60 minute(s) by intravenous route once daily
Prevention of disseminated candidiasis
- Infuse 50 mg over 1 hour(s) by intravenous route once daily
- Infuse 50 mg over 60 minute(s) by intravenous route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Intravascular hemolysis
Severe
Moderate
- Abnormal hepatic function tests
- Kidney disease with reduction in GFR
MYCAMINE (MICAFUNGIN SODIUM)
- Candida peritonitis
- Candidal septicemia
- Candidemia
- Disseminated candidiasis
- Esophageal candidiasis
- Prevention of disseminated candidiasis
- Fever
- Hypertension
- Hypocalcemia
- Hypokalemia
- Hypomagnesemia
- Body fluid retention
- Diarrhea
- Dyspepsia
- Flushing
- Headache disorder
- Hypoglycemic disorder
- Hypotension
- Nausea
- Phlebitis after infusion
- Vomiting
More Frequent
Severe
Less Severe
- Atrial fibrillation
- Hyperbilirubinemia
- Thrombocytopenic disorder
- Chills
- Insomnia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Anaphylaxis
- Anemia
- Delirium
- Hemolytic anemia
- Hepatic failure
- Hepatitis
- Injection site sequelae
- Intravascular hemolysis
- Kidney disease with reduction in GFR
- Neutropenic disorder
- Pancytopenia
- Pruritus of skin
- Renal failure
- Shock
- Skin rash
- Stevens-johnson syndrome
- Thrombotic thrombocytopenic purpura
- Toxic epidermal necrolysis
Less Severe
- Abdominal pain with cramps
- Facial edema
- Vasodilation of blood vessels
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Micafungin
Safety and efficacy not established age < 4 months. Limited reports on neonatal use.
- 1 Day – 119 Days
- Safety and efficacy not established age < 4 months. Limited reports on neonatal use.
Micafungin Sodium
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Micafungin Sodium
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Candida peritonitis | |
| B37.89 | Other sites of candidiasis |
| K65.0 | Generalized (acute) peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Candidal septicemia | |
| B37.7 | Candidal sepsis |
| Candidemia | |
| B37.7 | Candidal sepsis |
| Disseminated candidiasis | |
| B37.5 | Candidal meningitis |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B37.89 | Other sites of candidiasis |
| Esophageal candidiasis | |
| B37.81 | Candidal esophagitis |
| 0-9 | A-Z |
|---|---|
| B37.5 | Candidal meningitis |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.81 | Candidal esophagitis |
| B37.89 | Other sites of candidiasis |
| B37.89 | Other sites of candidiasis |
| K65.0 | Generalized (acute) peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Formulary Reference Tool